Krsnaa Diagnostics Q3 FY26 Results: Revenue Up, Profit Down on Tax Issues
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 3.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q3 FY26 and nine-month results ended December 31, 2025. Standalone Q3 revenue was Rs 1,594.32 mn versus Rs 1,651.57 mn a year ago, with PAT at Rs 164.92 mn versus Rs 216 mn. Consolidated nine-month revenue grew 9.2% to Rs 5,801.70 mn and PAT rose to Rs 597.11 mn from Rs 569.32 mn. Auditor MSKA flagged an ongoing income tax dispute with a Rs 513.86 mn demand; Rs 102.77 mn paid under protest, appeals filed, management sees no material impact.
Mixed quarter. Tax demand of Rs 513.86 mn remains an overhang, though management expects no material hit on financials.